Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy

Cancer Letters

Volumn 137, Issue 1, 1999, Pages 91-98

  Korbelik, Mladen ^a   Cecic, Ivana ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Anti tumor immunity; Immunodepletion; Mouse sarcoma; Photodynamic therapy; Photofrin; Tumor cure

Indexed keywords

INTERLEUKIN 2 RECEPTOR; PHOTOFRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE DEFICIENCY; LYMPHOID CELL; MACROPHAGE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SARCOMA; TUMOR IMMUNITY;

ANIMALS; FEMALE; IMMUNITY, CELLULAR; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEUTROPHILS; PHOTOCHEMOTHERAPY; RECEPTORS, INTERLEUKIN-2; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES;

EID: 0032926770     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00349-8     Document Type: Article

References (25)

1. Coffman R.L., Weissman I.L. B220: a B cell-specific member of the T200 glycoprotein family. Nature. 289:1981;681-683.
2. de Wree W.J.A., Essers M.C., DeBrujin H.S., Star W.M., Koster J.F., Sluiter W. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 56:1996;2908-2911.
3. de Wree W.J.A., Essers M.C., Koster J.F., Sluiter W. Role of interleukin 1 and granulocyte colony-stimulating factor in Photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res. 57:1997;2555-2558.
4. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90:1998;889-905.
5. Evans S., Matthews W., Perry R., Fraker D., Norton J., Pass H.I. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl. Cancer Inst. 82:1990;34-39.
6. Frey A.B. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762. J. Immunol. 156:1996;3841-3849.
7. Gallin J.I. Inflammation. Paul W.E. Fundamental Immunology. 1989;721 Raven Press, New York.
8. Gollnick S.O., Liu X., Owczarczak B., Musser D.A., Henderson B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57:1997;3904-3909.
9. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
10. + T cell-dependent tumour rejection. J. Exp. Med. 174:1991;1291-1298.
11. Korbelik M. Induction of tumour immunity by photodynamic therapy. J. Clin. Laser Med. Surg. 14:1996;329-334.
12. Korbelik M., Cecic I., Shibuya H. The role of nitric oxide in the response of cancerous lesions to photodynamic therapy. Pandalai S.G. Recent Research Developments in Photochemistry and Photobiology. 1998;267 Transworld Research Network, Trivandrum (India).
13. Korbelik M., Krosl G. Photosensitizer distribution and photosensitized damage of tumor tissues. Hönigsmann H., Jori G., Young A.R. The Fundamental Bases of Phototherapy. 1996;229 OEMF spa, Milan.
14. Korbelik M., Krosl G., Krosl J., Dougherty G.J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 56:1996;5647-5652.
15. Korbelik M., Naraparaju V.R., Yamamoto N. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br. J. Cancer. 75:1997;202-207.
16. Korbelik M., Cecic I. Enhancement of tumor response to photodynamic therapy by adjuvant mycobacterium cell wall treatment. J. Photochem. Photobiol. B: Biol. 44:1998;151-158.
17. Krosl G., Korbelik M., Dougherty G.J. Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy. Br. J. Cancer. 71:1995;549-555.
18. Krosl G., Korbelik M., Dougherty G.J. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res. 56:1996;3281-3286.
19. Levy M.H., Wheelock E.F. Effects of intravenous silica on immune and non-immune functions of the murine host. J. Immunol. 115:1975;41-48.
20. Nseyo U.O., Whalen R.K., Duncan M.R., Berman B., Lundhal S.L. Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology. 36:1990;167-171.
21. Pekarek L.A., Starr B.A., Toledano A.Y., Schreiber H. Inhibition of tumour growth by elimination of granulocytes. J. Exp. Med. 181:1995;435-440.
22. Rockwell S.C., Kallman R.F., Fajardo L.F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 49:1972;735-749.
23. Sarmiento M., Dialynas D.P., Lancki D.W., Wall K.A., Lorber M.I., Loken M.R., Fitch F.W. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:1982;135-169.
24. Symington F.W., Subbarao B., Mosier D.E., Sprent J. Lyb-8.2: a new cell antigen defined and characterized with a monoclonal antibody. Immunogenetics. 16:1982;381-391.
25. Zubler R.H., Lowenthal J.W., Erard F., Hashimoto N., Devos R., MacDonald H.R. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J. Exp. Med. 160:1984;1170-1183.